NASDAQ · PBH
Healthcare · Medical - Distribution
$46.47
Down-$1.50 (-3.23%)
Updated Sep 18, 2026, 11:17 PM
SID Score
5.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PBH closed at $46.47 after 20 trading sessions, down 8.02% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $47.20 | $47.485 | $45.90 | $46.47 | 504.03K |
| Sep 16, 2026 | $46.83 | $47.685 | $46.49 | $46.86 | 536.93K |
| Sep 15, 2026 | $47.22 | $48.25 | $46.38 | $46.68 | 767.13K |
| Sep 14, 2026 | $47.91 | $48.42 | $47.17 | $47.62 | 580.76K |
| Sep 11, 2026 | $47.68 | $47.75 | $46.4834 | $46.95 | 495.64K |
| Sep 10, 2026 | $49.37 | $49.51 | $47.29 | $47.34 | 513.59K |
| Sep 9, 2026 | $49.53 | $49.87 | $48.17 | $48.70 | 474.87K |
| Sep 8, 2026 | $51.67 | $51.67 | $49.73 | $49.79 | 418.33K |
| Sep 4, 2026 | $51.80 | $52.58 | $51.80 | $52.26 | 342.93K |
| Sep 3, 2026 | $53.45 | $53.83 | $51.86 | $52.56 | 449.1K |
| Sep 2, 2026 | $52.88 | $53.95 | $52.7326 | $52.83 | 440.01K |
| Sep 1, 2026 | $52.50 | $53.57 | $52.28 | $52.64 | 592.57K |
| Aug 31, 2026 | $51.97 | $52.455 | $51.08 | $51.78 | 472.24K |
| Aug 28, 2026 | $51.50 | $52.54 | $51.22 | $52.47 | 299.81K |
| Aug 27, 2026 | $51.11 | $51.845 | $51.10 | $51.21 | 304.47K |
| Aug 26, 2026 | $51.34 | $52.55 | $50.99 | $52.15 | 365.63K |
| Aug 25, 2026 | $51.80 | $52.055 | $51.17 | $51.45 | 368.85K |
| Aug 24, 2026 | $51.44 | $53.13 | $51.125 | $52.02 | 576.06K |
| Aug 21, 2026 | $50.48 | $51.37 | $49.91 | $51.31 | 390.33K |
| Aug 20, 2026 | $51.30 | $51.35 | $50.4158 | $50.52 | 336.81K |
The latest Smart Investors Daily articles mentioning PBH.
PBH research
Company profile and research snapshot.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 15, 2026 | Canaccord Genuity | Buy | — |
| May 14, 2026 | Oppenheimer | Perform | — |
| May 7, 2026 | Oppenheimer | Outperform | — |
| Feb 2, 2026 | Jefferies | Hold | — |
| Nov 7, 2025 | Canaccord Genuity | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Sep 10, 2026
Prestige Consumer Healthcare Inc. (PBH) Barclays 19th Annual Global Consumer Staples Conference September 10, 2026 12:45 PM EDTCompany ParticipantsRon...
Yahoo · Sep 8, 2026
TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the followin
Yahoo · Sep 2, 2026
Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.
Yahoo · Sep 1, 2026
Football does not always end when the final whistle blows. Findings from the inaugural DenTek Football Stress Test reveal that nearly eight in 10 football fans (78%) continue thinking about football after the game ends, while 77% say they have continued thinking about football after getting into bed. Nearly half have stayed up later than planned because of football, suggesting that for many fans, the game can follow them well into the night. With stress among the most common contributors to nigh
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PBH.
